Home Medicine Preventing SARS-CoV-2 transmission in the emergency department by implementing a separate pathway for patients with respiratory conditions
Article Open Access

Preventing SARS-CoV-2 transmission in the emergency department by implementing a separate pathway for patients with respiratory conditions

  • Fulwah Alqahtani , Marzouqah Alanazi , Wajdan Alassaf EMAIL logo , Fadilah Sfouq Aleanizy , Muna Aljahany , Mercy Joseph and Mohammad AlRaye
Published/Copyright: May 24, 2021

Abstract

Objectives

This study aimed to describe the development and implementation of a separated pathway to check and treat patients with a suspected/confirmed coronavirus disease 2019 (COVID-19) in the emergency department (ED) at King Abdullah bin Abdulaziz University Hospital in Riyadh.

Methods

We conducted a retrospective, descriptive longitudinal study from March to July 2020 by analyzing data of all confirmed cases of COVID-19 among ED visitors and healthcare workers in King Abdullah bin Abdulaziz University Hospital.

Results

During the study period, a total of 1,182 swab samples were collected for testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), of which 285 (24.1%) tested positive. Of the 285 cases of confirmed SARS-CoV-2 infection, 18 were healthcare workers and 267 were patients. As a result of using the respiratory pathway for COVID-19 patients, the hospital managed to limit transmission of SARS-CoV-2 not only between patients but also between patients and healthcare workers, while also containing the pandemic. There were no cases of nosocomial SARS-CoV-2 infection recorded among the patients who visited the ED or the flu clinic. All confirmed cases were community acquired and patients were cared for under constrained measures.

Conclusions

Implementing infection control measures and restricting those with respiratory symptoms to the ED pathway prevented nosocomial spread of SARS-CoV-2 infection in the ED.

Introduction

Most healthcare facilities provide services to patients with suspected or confirmed coronavirus disease 2019 (COVID-19) during COVID-19 pandemic [1]. This includes healthcare facilities providing both inpatient and outpatient services. Therefore, healthcare facility managers should implement infection control procedures in emergency departments (EDs) to prevent the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to patients and healthcare workers (HCWs) [1]. There are three patterns of COVID-19 transmission: sporadic community cases without an obvious source of transmission, family clusters resulting from contact with an infected family index case, and hospital-acquired infections between patients or from patients to HCWs [2], [3]. The main factors contributing to outbreaks include delayed diagnosis, inadequate infection control measures, inadequate triaging, failure to isolate patients with suspected COVID-19 and other high-risk patients with respiratory illness, crowding, and patients remaining in the ED for long periods. In most instances, effective control of hospital outbreaks can be accomplished by implementing proper infection control procedures. Prompt diagnosis, isolation, and management of suspected cases are vital, while limiting the number of contacts and hospital visits is also important, to the prevention of SARS-CoV-2 transmission. It is preferable to restrict the movement of patients with suspected COVID-19 to a separate pathway to prevent the spread of SARS-CoV2 among other patients and HCWs [2]. EDs in healthcare facilities are an important source of cases, as they provide care to patients who present without prior appointment, either as walk-ins or by an ambulance. EDs are usually found in hospitals or other primary care centers [4]. Because of the unplanned nature of patient arrivals, EDs must provide initial treatment for a broad spectrum of illnesses and injuries, some of which may be life-threatening, requiring immediate attention. In some countries, EDs have become important entry points for those without other means of access to medical care. Most hospital EDs operate 24 h a day, 7 days a week, although staffing levels may vary according to the patient volume [4].

During infectious disease outbreaks, it is particularly important to separate patients likely to be infected with the pathogen of concern from other patients in EDs. The ED pathway for managing patients with respiratory symptoms or who fit the risk criteria was developed in the context of the COVID-19 pandemic and does not replace routine clinical triage already in place to categorize patients into different urgency categories [5], [6].

This work is based on current data on the COVID-19 pandemic and experiences with other respiratory virus outbreaks in Saudi Arabia, including Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks between 2013 and 2016 [7]. A separate pathway was created within the ED department for any patient who complained of respiratory symptoms or fit the risk criteria; after initial analysis and diagnostic tests, they would then be discharged home with no ED treatment, discharged home after receiving ED treatment, or admitted to either the ward or intensive care unit.

This study aimed to design and implement a separate pathway in the ED of King Abdullah bin Abdulaziz University Hospital (KAAUH) which is in line with the recommendations of Ministry of health (MOH), to screen and treat patients with a suspected/confirmed diagnosis of COVID-19. It was believed that this respiratory pathway at the hospital would decrease cross-infection among patients and between patients and HCWs while also preventing the pandemic from spreading among other ED visitors.

Methods

Study design

This retrospective, descriptive longitudinal study was conducted between March and July, 2020, analyzing primary data for all confirmed positive cases of SARS-CoV-2 HCWs at KAAUH.

Ethical consideration

The study was carried out in accordance with the Declaration of Helsinki. The Institutional Review Board of Princess Nourah Bint Abdulrahman University had granted this research and exempt status, with log number 20-0212. The requirement for informed consent was waived because the analysis was based on the use of routinely-collected data.

The HCWs reported all patients who were tested in the hospital or the Infection Control Department and who tested positive. A log of was kept of the cases, the probable type of transmission, contact tracing, the symptoms, and the disease progress.

Respiratory pathway design

The hospital managers created pathways to standardize the process of managing suspected or confirmed COVID-19 cases and minimize the risk of spread of SARS-CoV-2 infection.

Emergency department

The first pathway was created for dealing with respiratory cases in the ED, which was split into two areas: the respiratory zone and clean zone as per the Saudi Arabia Ministry of Health (MOH) recommendation (Figure 1) [8], [9]. Each zone had a separate designated entrance, designated waiting rooms, examination/treatment rooms, and a primary screening area immediately near the entrance door, where an initial triage was carried out by a registered nurse wearing personal protection equipment to prevent droplet and contact spread. The nurse’s role was to check patients’ temperature, advise them on hand hygiene, provide them with masks, and determine their respiratory symptoms and COVID-19 risk factors as per the MOH/Centers for Disease Control and Prevention (CDC) criteria [9]. If patients who met the criteria accidentally walked into the clean zone, they would be identified immediately and directed to the respiratory zone.

Figure 1: 
Patients flow in emergency medicine department for respiratory illness cases.
Figure 1:

Patients flow in emergency medicine department for respiratory illness cases.

Patients were registered in the respiratory zone electronically, and waited in a specifically designed waiting area equipped with high efficiency particulate air (HEPA) filters and spaced waiting room chairs, in accordance with the social distancing recommendations.

Patients not meeting the admission criteria

Patients were later evaluated in the designated respiratory assessment rooms, and if they did not meet the admission criteria and their vital signs were stable, nasopharyngeal swabs were collected using airborne precautions, and they were discharged home with instructions on home isolation and when to seek medical advice. After each swab had been collected, terminal cleaning was conducted.

Patients meeting the admission criteria

If the patients’ vital signs were unstable, or they met the admission criteria, they were guided, individually, through a designated pathway (with a restricted entrance) into the respiratory zone treatment area, where initial management and investigations were conducted. When admission requests were placed, each patient was shifted, wearing a surgical mask, through the same designated pathway to the admission floor, using a designated elevator that was access controlled and labeled the “COVID-19 elevator” (Figure 1).

Transfer to quarantine building

The second pathway was for patient transfer to a quarantine building (a housing building, with single rooms, used to quarantine and isolate asymptomatic positive or suspected COVID-19 patients who do not have appropriate home isolation conditions). When the treating physician decided that the patient was to be transferred to the quarantine building, the infection control team were informed and created a log for the patient. The primary nurse communicated with the emergency medicine services (EMS) team to prepare the designated COVID-19 ambulance, which was then used to transfer the patient. Patients who had already been admitted were asked to wear surgical masks, and were escorted through the designated elevator to the respiratory zone in the ED, from where they were led to the ambulance for transfer, with the EMS team taking droplet contact precautions. The same route and steps were followed for ED patients who required admission. The ambulance used to transfer patients underwent terminal cleaning and fumigation after each transfer.

Outpatients flu clinic

In addition to receiving patients through ED, a designated Flu clinic was created near to the outpatient department it was equipped with HEPA filters, staffed by family medicine physicians and staff nurses. They were seeing and managing stable walk-in eligible patients (in order to decrease the load on ED) their working hours were the usual office working hours 8 am until 4 pm, and at one point when the number of suspected cases was high their working hours was increased to 8 pm.

The team in Flu clinic did the visual triage, assess the patient clinically, do the swabbing, prescribe medications and issues sick leaves if needed, in case they though that a patient may need intervention they will refer them to ED, where they will be escorted to wearing surgical mask and social distancing measures.

Results

During the COVID-19 epidemic in Saudi Arabia, a respiratory pathway was created in KAAUH that accepted patients and HCWs with suspected or confirmed COVID-19/SARS-CoV-2 infection. Swabs were collected from all categories of patients or HCWs with symptoms and those who had been in contact with someone with confirmed SARS-CoV-2 infection. During the study period, a total of 1,182 swabs were collected (Table 1), of which 285 (24.1%) were positive. Of the 285 cases of confirmed SARS-CoV-2 infection, 18 were HCWs and 267 were non HCW. Swabs were taken either at the ED or at the flu clinic. The percentages of swabs performed for patients at the ED and flu clinic were 53.2 and 46.8%, while the same for HCWs were 34.5 and 65.5%, respectively.

Table 1:

Number of swabs tested for SARS-CoV2 and the results.

Flu clinic, n (%) ED, n (%) Total, n (%)
Number of patients tested 620 (27.9%) 961 (43.2%) 1,221 (54.9%)
Positive 159 (7.1%) 267 (12%) 426 (19.1%)
Negative 461 (20.7%) 694 (31.2%) 1,155 (51.9%)
Number of HCW tested 420 (18.9%) 221 (9.9%) 641 (28.84%)
Positive 19 (0.8%) 18 (0.8%) 37 (1.6%)
Negative 401 (18%) 203 (9.1%) 604 (27.1%)
Total swabs 1,040 (46.8%) 1,182 (53.1%) 2,222
Positive 178 (8%) 285 (12.8%) 463 (20%)
Negative 862 (38.7%) 897 (40.3%) 1759 (79%)
  1. ED, emergency department; HCW, healthcare workers.

The demographic distribution of the patients and HCWs who had swabs collected in the ED and tested positive is shown in Table 2. Of the 285 positive cases, 43.2% were male and 56.8% were female. Of the HCWs, 18/221 (6.3%) tested positive, of whom 11 (3.9%) were males and 7 (2.4%) were females. The total number of infected ED persons was five (four male, and one female).

Table 2:

Demographic analysis of positive swabs for patients and HCWs done in the ED.

Sex
Category Male Female Total
Healthcare workers
Count 11 7 18
% Within sex 8.9% 4.3%
% of total 3.9% 2.4% 6.3%
Patients
Count 112 155 267
% Within sex 91.1% 95.7%
% of total 39.3% 54.4% 93.7%
Total
Count 123 162 285
% of total 43.2% 56.8% 100%

Discussion

SARS-CoV-2 is mainly transmitted through respiratory droplets generated by an infected person who coughs or sneezes. A recent report by the US National Institutes of Health revealed that respiratory droplets could settle on surfaces and the virus could remain viable for several hours to days [10]. Moreover, transmission can also occur through hands that come in contact with mucosal surfaces, such as nose, mouth, and eyes, of an infected person [3]. KAAUH has applied the specific recommendations and standard operating procedure prescribed by the World Health Organization to deal with all COVID-19 cases [11]. Since the start of the COVID-19 pandemic, all individuals in the community, community health workers, HCWs, healthcare managers, as well as public health and infection prevention and control professionals have begun wearing masks and protective equipment [8], [12]. The same rules have been applied at KAAUH. During the early stage of COVID-19, the symptoms are non-specific[13], [14]. Infected individuals could be symptomatic, displaying malaise, cough, and fever, or asymptomatic and yet infectious. The accuracy of early diagnosis based on combined chest computed tomography and nucleic acid testing can reach 97%. In the late stages of infection, expiratory dyspnea occurs and in severe cases respiratory distress syndrome, acute circulatory failure, or renal failure can occur. Until now, no specific effective therapeutic protocol is known. The current treatment methods are empirical, based on symptoms, and consist of antibiotics and antiviral drugs, as well as respiratory support through mechanical ventilation [13], [14]. The large number of infected persons and the rapid spread of COVID-19 have resulted in an extraordinary public health emergency. This epidemic is a serious challenge to the entire world and in particular to the medical system and its ability to manage such pandemics [15]. Herein, we have described the experience in the ED of KAAUH and the protection measures implemented during the creation of a respiratory pathway. Because of this new pathway and the strict preventive protocols, there have been no additional cases of infection among the medical staff and the patients.

KAAUH is a relatively new hospital, which opened in 2017. The hospital capacity is 192 beds with 23 ED beds. During the COVID-19 pandemic, the hospital efficiently created a respiratory pathway within the ED to categorize patients into different conditions of urgency of either with regard to whether they were suspected to be COVID-19 positive. The pathway does not replace any ED routine already established in healthcare facilities. It has all requirements such as the “eyeball test” (initial rapid assessment), triage rooms, swab room, negative pressure rooms, and extra rooms with HEPA filters. HCWs staffing the respiratory pathway are all fit, tested for COVID-19, and none of them have chronic diseases or asthma; nurses rotate in and out of the zone, separately from the housekeepers and porters. The pathway is also equipped with a portable X-ray machine, shower rooms, and clothes for all staff, as well as laundry services; however, it does not have separate ablution facilities, eating areas, or a designated card-controlled admission elevator. All patients with respiratory symptoms can benefit from direct admission and high turnover to minimize the time that they spend in the ED. Moreover, it is important for HCWs to stay up-to-date on relevant information and remain on high alert, prepared to handle COVID-19 cases and direct admission requests, which are often made prior to the patients’ arrival. After implementing all infection control measures and separating the ED into the standard ED and the respiratory pathway to control COVID-19 cases, KAAUH managed to prevent the transmission of the infection between ED visitors and HCWs. KAAUH has managed 358 positive cases among patients and HCWs, all of which were confirmed to be community acquired; and no nosocomial transmission has been documented. One limitation to this study is the relatively small number of HCWs and ED visitors, which may limit the generalizability of results. Additionally, this pathway only helps if the patients mentioned that he/she had contact of positive case, otherwise if they presented with a complaint that was not a part of the case definition issued by MOH they won’t be picked up. In order to maintain the future functionality of this pathway extra staff will be required (physicians, nurses, allied health providers, cleaners and security personal) as the number of cases will increase (both suspected and clean cases).

Multiple indicators can be utilized in future to assess the benefits of this pathway, length of waiting time, time of registration until disposition, and staff psychological wellbeing in both ED areas.

Recommendations

Implementing strict infection control measures including designated policies to deal with cases during epidemics/pandemics, and formulating a clear and detailed management plan including movement allocations and steps is of critical importance in protecting HCWs. Simplifying plans using visual aids and concise algorithms proved to be effective in our research and is highly recommended.


Corresponding author: Dr. Wajdan Alassaf, MD, Department of Emergency Medicine, College of Medicine, Princess Nourah bint Abdulrahman University Hospital, 84428, Riyadh, Saudi Arabia, Phone: +966555147527, E-mail:

Funding source: Research Center of the Female Scientific and Medical Colleges

  1. Research funding: This research project was supported by a grant from the “Research Center of the Female Scientific and Medical Colleges”, Deanship of Scientific Research, King Saud University.

  2. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Competing interest: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: The study was carried out in accordance with the Declaration of Helsinki. The Institutional Review Board of Princess Nourah Bint Abdulrahman University had granted this research and exempt status, with log number 20-0212.

References

1. Walker, LL. Inpatient and emergency department utilization: the effect of distance, social class, age, sex, and marital status. JACEP 1976;5:105–10. https://doi.org/10.1016/s0361-1124(76)80187-6.Search in Google Scholar

2. Al-Tawfiq, JA, Auwaerter, PG. Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature. J Hosp Infect 2019;101:20–9. https://doi.org/10.1016/j.jhin.2018.05.021.Search in Google Scholar PubMed PubMed Central

3. World Health Organization. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations: scientific brief; 2020. Available from: https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations [Accessed 9 Sep 2020].Search in Google Scholar

4. Oredsson, S, Jonsson, H, Rognes, J, Lind, L, Göransson, KE, Ehrenberg, A, et al.. A systematic review of triage-related interventions to improve patient flow in emergency departments. Scand J Trauma Resusc Emerg Med 2011;19:43. https://doi.org/10.1186/1757-7241-19-43.Search in Google Scholar PubMed PubMed Central

5. Sørup, CM, Jacobsen, P, Forberg, JL. Evaluation of emergency department performance – a systematic review on recommended performance and quality-in-care measures. Scand J Trauma Resusc Emerg Med 2013;21:1–14. https://doi.org/10.1186/1757-7241-21-62.Search in Google Scholar PubMed PubMed Central

6. Van Uden, CJ, Winkens, RAG, Wesseling, G, Fiolet, HF, van Schayck, OC, Crebolder, HF. The impact of a primary care physician cooperative on the caseload of an emergency department: the Maastricht integrated out‐of‐hours service. J Gen Intern Med 2005;20:612–7. https://doi.org/10.1111/j.1525-1497.2005.0091.x.Search in Google Scholar PubMed PubMed Central

7. Madran, B, Keske, S, Uzun, S, Taymaz, T, Bakır, E, Bozkurt, İ, et al.. Effectiveness of clinical pathway for upper respiratory tract infections in emergency department. Int J Infect Dis 2019;83:154–9. https://doi.org/10.1016/j.ijid.2019.04.022.Search in Google Scholar PubMed

8. World Health Organization. Infection prevention and control during health care when COVID-19 is suspected: interim guidance; 2020. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC-2020.4 [Accessed 9 Sep 2020].Search in Google Scholar

9. Barry, M, Al Amri, M, Memish, ZA. COVID-19 in the shadows of MERS-CoV in the Kingdom of Saudi Arabia. J Epidemiol Glob Health 2020;10:1–3. https://doi.org/10.2991/jegh.k.200218.003.Search in Google Scholar PubMed PubMed Central

10. Van Doremalen, N, Bushmaker, T, Morris, DH, Holbrook, MG, Gamble, A, Williamson, BN, et al.. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020;382:1564–7. https://doi.org/10.1056/nejmc2004973.Search in Google Scholar

11. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): standard operating procedure (SOP) for triage of suspected COVID-19 patients in non-US healthcare settings: early identification and prevention of transmission during triage. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/sop-triage-prevent-transmission.html [Accessed 31 Jul 2020].Search in Google Scholar

12. World Health Organization. Rational use of personal protective equipment for coronavirus disease ( COVID-19) and considerations during severe shortages: interim guidance; 2020. Available from: https://www.who.int/publications/i/item/rational-use-of-personal-protective-equipment-for-coronavirus-disease-(covid-19)-and-considerations-during-severe-shortages [Accessed 9 Sep 2020].Search in Google Scholar

13. Guan, WJ, Ni, ZY, Hu, Y, Liang, WH, Ou, CQ, He, JX, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20. https://doi.org/10.1056/NEJMoa2002032.Search in Google Scholar PubMed PubMed Central

14. Wang, D, Hu, B, Hu, C, Zhu, F, Liu, X, Zhang, J, et al.. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. J Am Med Assoc 2020;323:1061–9. https://doi.org/10.1001/jama.2020.1585.Search in Google Scholar PubMed PubMed Central

15. Wang, X, Wang, MJ, Jiang, XB, Wang, HJ, Zhao, HY, et al.. Strategies for prevention and control of 2019 novel coronavirus infection among medical staff. Neurosurgery 2020;87:E57–62. https://doi.org/10.1093/neuros/nyaa117.Search in Google Scholar PubMed PubMed Central

Received: 2020-10-09
Accepted: 2021-03-26
Published Online: 2021-05-24

© 2021 Fulwah Alqahtani et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Swarna Prashana – faith in the embrace of research
  4. A review on the concept of aging in Ayurveda literature
  5. Ethno-pharmacology of Asaroon (Asarum europaeum L.) with special reference to Unani System of Medicine
  6. Is Trikatu an ayurvedic formulation effective for the management of flu-like illness? A narrative review
  7. The anti-cancer properties of neem (Azadirachta indica) through its antioxidant activity in the liver: its pharmaceutics and toxic dosage forms. A literature review
  8. The role of acupuncture for myofascial pain syndrome (MPS) in interventional pain management
  9. Research Articles
  10. Identification of phenolic compounds in the buds of Algerian Pistacia atlantica desf. Subsp. atlantica by antioxidant activity guided fractionation
  11. Optimization of water-based ultrasonic-microwave assisted extraction (UMAE) of bioactive compounds from Garcinia mangostana pericarp
  12. Proximate analysis, HPTLC finger print analysis and multi spectrometric analysis of Strychnos nux-vomica nuts
  13. Amelioration of sodium fluoride induced oxidative stress by Cynometra travancorica Bedd in mice
  14. The effects of saffron petals and damask rose petals on biochemical and inflammatory measurements
  15. Ethanolic extract of Achillea wilhelmsii C. Koch improves pulmonary function and inflammation in LPS-induced acute lung injury mice
  16. Interaction between properties of commercial Australian honey and saliva: in vitro exploratory study of a potential mechanism in the treatment of oral mucositis
  17. The potential of immature poken (Citrus reticulata) extract in the weight management, lipid and glucose metabolism
  18. Effect of the beta-adrenergic blockade on intestinal lactate production and glycogen concentration in dogs infused with hexoses
  19. Investigating the effect of the Teucrium polium aqueous extract on the liver of the streptozotocin-induced diabetic rats
  20. Synergistic effects of high-intensity interval training (HIIT) and intake of nettle on serum levels of chemerin and beta cells function in type 2 diabetic rats
  21. The effect of Cinnamomum cassia extract on oxidative stress in the liver and kidney of STZ-induced diabetic rats
  22. Protective role of Sterculia tragacantha aqueous extract on pancreatic gene expression and oxidative stress parameters in streptozotocin-induced diabetic rats
  23. Ameliorating activity of polyphenolic-rich extracts of Basella rubra L. leaves on pancreatic β-cell dysfunction in streptozotocin-induced diabetic rats
  24. Amelioration of related complications by the combined usage of Gymnadenia orchidis Lindl and pumpkin seed in type 2 diabetic mice
  25. The effect of Madhumeha Kusumakar Rasa – an Ayurved medicine – in insulin resistance
  26. Anti-obesity effects of the n-butanol fraction of the methanolic leaf extract of Artemisia campestris from Tunisian pharmacopeia in male Wistar rats
  27. Compensatory depression of arterial pressure and reversal of ECG abnormalities by Annona muricata and Curcuma longa in hypertensive Wistar rats
  28. Preventing SARS-CoV-2 transmission in the emergency department by implementing a separate pathway for patients with respiratory conditions
  29. Clinical significance of serum gonadotropin and androgen levels among Egyptian overweight/obese pubertal girls
  30. Preference between serum homocysteine and urinary periostin as early predictive biomarkers of renal dysfunction among uncontrolled diabetics
  31. Mizaj assessment in multiple sclerosis patients based on Persian Medicine
  32. Immediate effects of the practise of Sheethali pranayama on heart rate and blood pressure parameters in healthy volunteers
  33. Effects of 12 sessions of steam bath intervention on spirometry parameters among healthy adult volunteers
  34. The effects of psychological counseling and acupressure based on couple therapy procedure for alleviation of vomiting and nausea in pregnant women in Iran country
  35. “The immediate effect of neutral spinal compress on heart rate variability in hypertensive individuals”
  36. Effect of whole-body vibration after a resistance exercise bout on heart rate variability in hypertensive population
  37. Wet-cupping on calf muscles in polycystic ovary syndrome: a quasi-experimental study
  38. Auricular field nerve stimulation using the NSS-2 BRIDGE® device as an alternative to opioids following kidney donor surgery
  39. Evaluation of general body temperament and uterine dystemperament in amenorrhoea: a cross-sectional analytical study
  40. Short Communication
  41. Isolation, characterization, and antimicrobial activity of communic acid from Juniperus phoenicea
  42. Letter to the Editor
  43. Can silymarin ameliorate β-thalassemia major-induced osteopenia/osteoporosis?
  44. Case Reports
  45. Management of psoriasis with Ayurveda Panchakarma and Manibhadragula as Shodhana Rasayana – a case report
  46. Psychogenic pseudo-myasthenic ptosis – management with ayurvedic medicines and Smriti meditation
  47. Education Forum
  48. Tongue stretching: technique and clinical proposal
  49. Simulation-based ventilatory training for the caregivers at primary and rural health care workers in Central India for dealing with COVID-19 pandemic: recommendations
Downloaded on 22.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jcim-2020-0422/html
Scroll to top button